Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00264849
Status:
COMPLETED
Last Update Posted:
2018-06-29
First Post:
2005-12-12
Brief Title:
Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma
Sponsor:
Novartis
Organization:
Novartis